Adjuvant antibiotic activity of acidic sophorolipids with potential for facilitating wound healing

Helen Lydon, Niki Baccile, Breedge Callaghan, R Marchant, CA Mitchell, Ibrahim Banat

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The sophorolipid class of biosurfactants are finding increasing use in personal care as well as pharmaceutical products and have the potential to disrupt biofilm formation and inhibit growth in a variety of clinically relevant organisms. In order to investigate potential biomedical applications of sophorolipids derived from non-pathogenic organisms, we fractionated and purified glycolipid biosurfactant sophorolipids produced by the yeast Starmerella bombicola, which yielded both acidic C 18-1 acetylated and non-acetylated congeners that were essentially free from other contaminants (>95% purity). These acidic sophorolipids have antimicrobial activities against the nosocomial infective agents Enterococcus faecalis and Pseudomonas aeruginosa with significant reduction in c.f.u.'s at concentrations as low as 5 mgmL-1 In addition, the sophorolipid showed similar effects when combined with kanamycin or cefotaxime against the same two bacterial strains. As a potential use of these sophorolipids is as a component of topically applied creams for treatment of wound infections, it is clear that they must have no demonstrable adverse effect on wound healing. To assess this we evaluated mammalian cell toxicity in vitro using viability tests and revealed no adverse effect on either endothelial or keratinocyte derived cell lines with sophorolipid concentrations
LanguageEnglish
PagesAAC.02547-16
JournalAntimicrobial Agents and Chemotherapy
VolumeEpub
Early online date27 Feb 2017
DOIs
Publication statusE-pub ahead of print - 27 Feb 2017

Fingerprint

Kanamycin
Cefotaxime
Enterococcus faecalis
Glycolipids
Wound Infection
Biofilms
Keratinocytes
Wound Healing
Pseudomonas aeruginosa
Yeasts
Anti-Bacterial Agents
Cell Line
Growth
Pharmaceutical Preparations
In Vitro Techniques

Keywords

  • acidic sophorolipids
  • microbial pathogens
  • growth inhibition
  • endothelium
  • keratinocytes
  • in vivo
  • wound healing

Cite this

@article{70e706ce088541f98b8ba5551f5bb971,
title = "Adjuvant antibiotic activity of acidic sophorolipids with potential for facilitating wound healing",
abstract = "The sophorolipid class of biosurfactants are finding increasing use in personal care as well as pharmaceutical products and have the potential to disrupt biofilm formation and inhibit growth in a variety of clinically relevant organisms. In order to investigate potential biomedical applications of sophorolipids derived from non-pathogenic organisms, we fractionated and purified glycolipid biosurfactant sophorolipids produced by the yeast Starmerella bombicola, which yielded both acidic C 18-1 acetylated and non-acetylated congeners that were essentially free from other contaminants (>95{\%} purity). These acidic sophorolipids have antimicrobial activities against the nosocomial infective agents Enterococcus faecalis and Pseudomonas aeruginosa with significant reduction in c.f.u.'s at concentrations as low as 5 mgmL-1 In addition, the sophorolipid showed similar effects when combined with kanamycin or cefotaxime against the same two bacterial strains. As a potential use of these sophorolipids is as a component of topically applied creams for treatment of wound infections, it is clear that they must have no demonstrable adverse effect on wound healing. To assess this we evaluated mammalian cell toxicity in vitro using viability tests and revealed no adverse effect on either endothelial or keratinocyte derived cell lines with sophorolipid concentrations",
keywords = "acidic sophorolipids, microbial pathogens, growth inhibition, endothelium, keratinocytes, in vivo, wound healing",
author = "Helen Lydon and Niki Baccile and Breedge Callaghan and R Marchant and CA Mitchell and Ibrahim Banat",
year = "2017",
month = "2",
day = "27",
doi = "10.1128/AAC.02547-16",
language = "English",
volume = "Epub",
pages = "AAC.02547--16",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",

}

Adjuvant antibiotic activity of acidic sophorolipids with potential for facilitating wound healing. / Lydon, Helen; Baccile, Niki; Callaghan, Breedge; Marchant, R; Mitchell, CA; Banat, Ibrahim.

In: Antimicrobial Agents and Chemotherapy, Vol. Epub, 27.02.2017, p. AAC.02547-16.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adjuvant antibiotic activity of acidic sophorolipids with potential for facilitating wound healing

AU - Lydon, Helen

AU - Baccile, Niki

AU - Callaghan, Breedge

AU - Marchant, R

AU - Mitchell, CA

AU - Banat, Ibrahim

PY - 2017/2/27

Y1 - 2017/2/27

N2 - The sophorolipid class of biosurfactants are finding increasing use in personal care as well as pharmaceutical products and have the potential to disrupt biofilm formation and inhibit growth in a variety of clinically relevant organisms. In order to investigate potential biomedical applications of sophorolipids derived from non-pathogenic organisms, we fractionated and purified glycolipid biosurfactant sophorolipids produced by the yeast Starmerella bombicola, which yielded both acidic C 18-1 acetylated and non-acetylated congeners that were essentially free from other contaminants (>95% purity). These acidic sophorolipids have antimicrobial activities against the nosocomial infective agents Enterococcus faecalis and Pseudomonas aeruginosa with significant reduction in c.f.u.'s at concentrations as low as 5 mgmL-1 In addition, the sophorolipid showed similar effects when combined with kanamycin or cefotaxime against the same two bacterial strains. As a potential use of these sophorolipids is as a component of topically applied creams for treatment of wound infections, it is clear that they must have no demonstrable adverse effect on wound healing. To assess this we evaluated mammalian cell toxicity in vitro using viability tests and revealed no adverse effect on either endothelial or keratinocyte derived cell lines with sophorolipid concentrations

AB - The sophorolipid class of biosurfactants are finding increasing use in personal care as well as pharmaceutical products and have the potential to disrupt biofilm formation and inhibit growth in a variety of clinically relevant organisms. In order to investigate potential biomedical applications of sophorolipids derived from non-pathogenic organisms, we fractionated and purified glycolipid biosurfactant sophorolipids produced by the yeast Starmerella bombicola, which yielded both acidic C 18-1 acetylated and non-acetylated congeners that were essentially free from other contaminants (>95% purity). These acidic sophorolipids have antimicrobial activities against the nosocomial infective agents Enterococcus faecalis and Pseudomonas aeruginosa with significant reduction in c.f.u.'s at concentrations as low as 5 mgmL-1 In addition, the sophorolipid showed similar effects when combined with kanamycin or cefotaxime against the same two bacterial strains. As a potential use of these sophorolipids is as a component of topically applied creams for treatment of wound infections, it is clear that they must have no demonstrable adverse effect on wound healing. To assess this we evaluated mammalian cell toxicity in vitro using viability tests and revealed no adverse effect on either endothelial or keratinocyte derived cell lines with sophorolipid concentrations

KW - acidic sophorolipids

KW - microbial pathogens

KW - growth inhibition

KW - endothelium

KW - keratinocytes

KW - in vivo

KW - wound healing

U2 - 10.1128/AAC.02547-16

DO - 10.1128/AAC.02547-16

M3 - Article

VL - Epub

SP - AAC.02547-16

JO - Antimicrobial Agents and Chemotherapy

T2 - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

ER -